Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Rita Rachmani"'
Autor:
Rita Rachmani, Mordchai Ravid
Publikováno v:
European Journal of Internal Medicine. 16:154-159
Diabetes mellitus is rapidly evolving as the epidemic of the 21st century. The presently estimated number of 190 million is predicted to grow to over 300 million by the year 2025. Cardiovascular (CVD) morbidity and mortality is two to five times high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e51425cb7c76503aa2586e512f240edc
https://doi.org/10.1016/j.ejim.2004.10.016
https://doi.org/10.1016/j.ejim.2004.10.016
Publikováno v:
Diabetes, Obesity and Metabolism. 6:63-68
Aim: Acarbose, a glucose oxidase inhibitor, delays the absorption of glucose thus reducing post-prandial blood glucose level, haemoglobin A1c (HbA1c) and insulin resistance in patients with diabetes mellitus and in subjects with impaired glucose tole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f427d27851ff5440a139911a034fed8d
https://doi.org/10.1111/j.1463-1326.2004.00317.x
https://doi.org/10.1111/j.1463-1326.2004.00317.x
Autor:
Zohar Levy, Ayana Dvir, Dror Harats, Svetlana Trestman, Rita Rachmani, Mordchai Ravid, Aviv Shaish
Publikováno v:
European Journal of Internal Medicine. 14:479-483
Background: Solid evidence suggests that atheroscleosis is associated with immune reactions. Most of the activated T cells in the plaque are T helper 1 subtype (Th1), which secrete interferon-gamma (IFN-gamma), now generally accepted as a proatheroge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05012a512f6bc759336c8dc0a164bc0d
https://doi.org/10.1016/j.ejim.2003.08.010
https://doi.org/10.1016/j.ejim.2003.08.010
Publikováno v:
European Journal of Internal Medicine. 13:428-433
BACKGROUND: The strict limiting criteria for the use of metformin in diabetes mellitus stem largely from reports, in the 1970s, of mortality and lactic acidosis associated with phenformin. Data about metformin are less clear and are based mainly on c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2678e080fac16e229b9d68e55d18ac9e
https://doi.org/10.1016/s0953-6205(02)00131-0
https://doi.org/10.1016/s0953-6205(02)00131-0
Publikováno v:
Clinical Pharmacology & Therapeutics. 72:302-307
Objectives Lipoprotein oxidation, dyslipidemia, and hypertension are important underlying causes of accelerated atherosclerosis in patients with diabetes mellitus. The potential of antihypertensive medications to reduce lipid oxidation is, therefore,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6b6d13841c0076323b1dacda7b4df7a
https://doi.org/10.1067/mcp.2002.127110
https://doi.org/10.1067/mcp.2002.127110
Autor:
Merav Lidar, Inna Slavachevski, Zohar Levi, Elizabeth Half-Onn, Rita Rachmani, Mordchai Ravid
Publikováno v:
Diabetes Research and Clinical Practice. 49:187-194
Objective: To examine the validity of the time honored threshold value for microalbuminuria of 30 mg/24 h, by analyzing an 8-year follow-up data of 599 patients with diabetes mellitus type 2, normal blood pressure and base-line albumin excretion rate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdc98d9571357ae4e8ae6b83e6aef2ad
https://doi.org/10.1016/s0168-8227(00)00155-8
https://doi.org/10.1016/s0168-8227(00)00155-8
Publikováno v:
Scopus-Elsevier
OBJECTIVE: To compare the effect of enalapril with long-acting nifedipine on orthostatic hypotension in older patients. DESIGN: A prospective, double blinded, cross-over study. SETTING: The outpatient clinic of a university hospital. PARTICIPANTS: Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b91ef74ec67397cfb1d29f25015a7ac
https://doi.org/10.1111/j.1532-5415.2000.tb04757.x
https://doi.org/10.1111/j.1532-5415.2000.tb04757.x
Publikováno v:
Nephron. 80:175-182
α-Adrenergic blockers are potential alternative antihypertensive agents for diabetic patients. Data on their relative efficacy and their effect on kidney function and albuminuria are very limited however. 76 patients with diabetes type 2, hypertensi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4546bc251bf536c226e789bf4772f7cc
https://doi.org/10.1159/000045163
https://doi.org/10.1159/000045163
Publikováno v:
Nephrology Dialysis Transplantation. 15:2050-2052
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba9c13b4811d896381abeb95e0c57fa9
https://doi.org/10.1093/ndt/15.12.2050
https://doi.org/10.1093/ndt/15.12.2050
Publikováno v:
European Journal of Internal Medicine. 11:48-50
Two hundred and fifty patients with diabetes mellitus type 2, normal blood pressure, normal kidney function and normo- or microalbuminuria were included in two prospective, controlled studies of 5- and 6-year duration. The patients were randomized to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2683bde6c48cf49f6f73659cee2e87a2
https://doi.org/10.1016/s0953-6205(99)00068-0
https://doi.org/10.1016/s0953-6205(99)00068-0